home / stock / ptct / ptct news


PTCT News and Press, PTC Therapeutics Inc. From 07/17/23

Stock Information

Company Name: PTC Therapeutics Inc.
Stock Symbol: PTCT
Market: NASDAQ
Website: ptcbio.com

Menu

PTCT PTCT Quote PTCT Short PTCT News PTCT Articles PTCT Message Board
Get PTCT Alerts

News, Short Squeeze, Breakout and More Instantly...

PTCT - PTC Therapeutics Appoints Experienced Healthcare Finance Strategist Pierre Gravier as Chief Financial Officer

PTC Therapeutics Appoints Experienced Healthcare Finance Strategist Pierre Gravier as Chief Financial Officer PR Newswire SOUTH PLAINFIELD, N.J. , July 17, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointment of Pierre Grav...

PTCT - PTC Therapeutics Announces Virtual Presentation on Phenylketonuria (PKU) and Sepiapterin

PTC Therapeutics Announces Virtual Presentation on Phenylketonuria (PKU) and Sepiapterin PR Newswire SOUTH PLAINFIELD, N.J. , July 11, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT), announced today that the company will provide a virtual presen...

PTCT - PTC Therapeutics Announces Results from MIT-E Clinical Trial of Vatiquinone for the Treatment of Mitochondrial Disease Associated Seizures

PTC Therapeutics Announces Results from MIT-E Clinical Trial of Vatiquinone for the Treatment of Mitochondrial Disease Associated Seizures PR Newswire SOUTH PLAINFIELD, N.J. , June 29, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today th...

PTCT - PTC Therapeutics Shares Positive Interim Data from PIVOT-HD Clinical Trial in Huntington's Disease Patients

PTC Therapeutics Shares Positive Interim Data from PIVOT-HD Clinical Trial in Huntington's Disease Patients PR Newswire - D ose-dependent lowering of blood Huntingtin (HTT) protein levels at 12 weeks - - Favorable tolerability profile with no treatment-related se...

PTCT - PTC Therapeutics: Rare Disease Specialist's Stock In Danger Of Slipping Further

2023-05-25 12:40:30 ET Summary I was bearish on PTC in my June 2022 note. Despite the stock having gained marginally since, I'm still expecting a downward correction in valuation. PTC Therapeutics is a rare disease specialist that earned $220m of revenues in Q123, primarily from i...

PTCT - Reata adds 21% as PTC's Friedreich's ataxia drug fails Phase 3 trial

2023-05-24 14:26:51 ET Shares of Reata Pharmaceuticals ( NASDAQ: RETA ) and PTC Therapeutics ( PTCT ) moved in opposite directions on Wednesday after the latter faced a setback for vatiquinone, a Phase 3 candidate for the neuromuscular disorder Friedreich's ataxia (FA). Whil...

PTCT - WKEY, BHG and EEIQ among mid-day movers

2023-05-24 12:53:19 ET Gainers: Minority Equality Opportunities Acquisition ( MEOA ) +176% . Enveric Biosciences ( ENVB ) +82% . QuantaSing Group ( QSG ) +61% . EpicQuest Education Group ( EEIQ ) +51% . GigaCloud Technology ( GCT ) ...

PTCT - Enveric, Zura top healthcare gainers; PTC Therapeutics, CohBar lead losers pack

2023-05-24 10:07:34 ET Gainers: Enveric Biosciences ( ENVB ) +100% . Zura Bio ( ZURA ) +37% . Kamada ( KMDA ) +19% . Organogenesis ( ORGO ) +16% . OptimizeRx ( OPRX ) +14% . Losers: PTC Therapeutics ( PTCT ) -24% ....

PTCT - PTC abandons preclinical gene therapy programs, cuts staff; CFO departs

2023-05-24 05:11:28 ET PTC Therapeutics ( NASDAQ: PTCT ) has decided to discontinue its preclinical and early research programs in its gene therapy platform and to reduce its workforce by ~8%. In addition, the company informed its CFO Emily Hill that her employment will be ...

PTCT - PTC Therapeutics Announces Topline Results from Vatiquinone MOVE-FA Registration-Directed Trial

PTC Therapeutics Announces Topline Results from Vatiquinone MOVE-FA Registration-Directed Trial PR Newswire - Conference call and webcast to be held at 5:00 pm EDT - SOUTH PLAINFIELD, N.J. , May 23, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NA...

Previous 10 Next 10